BIVI

Biovie Inc

• Reuters·04/01 22:27

  BioVie publishes corporate presentation on bezisterim pipeline catalysts in Parkinson’s, Long Covid

• Reuters·03/12 12:05

  BioVie to present SUNRISE-PD bezisterim poster at AD/PD 2026

• Reuters·02/23 13:04

  BioVie to Host Live Investor Webinar and Q&A Session with CEO Cuong Do

• Benzinga·02/12 13:13

  BioVie Announces Its Two Abstracts From Studies On Bezisterim To Treat Alzheimer's Disease, Long COVID Accepted At 2026 American College of Psychiatrists Annual Meeting

• Reuters·02/12 13:01

  BioVie Inc. Announces Phase 2 and 3 Clinical Trials of Bezisterim for Alzheimer's and Long COVID

• Reuters·01/26 11:03

  OPTION THERAPEUTICS INC SAYS THINKEQUITY IS THE UNDERWRITER TO IPO

• Reuters·01/10 18:53

  BioVie Inc. unveils new data on bezisterim's potential in Parkinson's and Alzheimer's therapies

• Benzinga·01/08 13:12

  BioVie Completes Enrollment Of 60 Patients In Phase 2 SUNRISE-PD Clinical Trial Evaluating Bezisterim On Motor And Non-Motor Symptoms In Individuals With Early-Stage PD

• Reuters·01/08 13:02

  BioVie Completes Enrollment for Phase 2 SUNRISE-PD Trial Testing Bezisterim in Early Parkinson’s Disease

• Reuters·01/08 13:00

  BIOVIE COMPLETES ENROLLMENT IN PHASE 2 SUNRISE-PD TRIAL IN EARLY PARKINSON’S DISEASE

• Reuters·01/08 13:00

  BIOVIE INC - TOPLINE RESULTS FROM SUNRISE-PD TRIAL EXPECTED IN 1H 2026

• NASDAQ·12/11/2025 17:00

  What Makes BioVie (BIVI) a New Buy Stock

• Reuters·12/08/2025 21:05

  Halozyme Therapeutics Elects Jim Lang to Board of Directors

• NASDAQ·11/21/2025 04:39

  Biotech Stocks Swing After Hours: Delcath Rises On Buyback, BioVie And Cassava Rebound

• TipRanks·11/12/2025 22:37

  BioVie Stockholders Approve Key Proposals at Annual Meeting